Why Was Covishield Denied 'Green Pass' by European Medicine Agency Republic World - 30 Apr 2024 Why Was Covishield Denied 'Green Pass' by European Medicine Agency ... More
EMA awards double validation for Daiichi Sankyo and AstraZeneca’s cancer ADC Pharmaceutical Technology - 04 Mar 2024 EMA awards double validation for Daiichi Sankyo and AstraZeneca’s cancer ADC ... More
EMA Validates Parallel Applications for Datopotamab Deruxtecan in Two Types of Cancer Pharmaceutical Technology Magazine - 08 Mar 2024 EMA Validates Parallel Applications for Datopotamab Deruxtecan in Two Types of Cancer ... More
AstraZeneca and Daiichi Sankyo's Dato-DXd validated by EMA for lung and breast cancer treatment DirectorsTalk Interviews - 04 Mar 2024 AstraZeneca and Daiichi Sankyo's Dato-DXd validated by EMA for lung and breast cancer treatment ... More
AstraZeneca Admits In Court Docs Covid Vaccine Can Cause RARE Side Effect, But What Does This Mean? MSN - 29 Apr 2024 AstraZeneca Admits In Court Docs Covid Vaccine Can Cause RARE Side Effect, But What Does This Mean? ... More
Viewpoint: EU pharma reform will stifle innovation, says AstraZeneca's Stefan Woxström Science Business - 26 Oct 2023 Viewpoint: EU pharma reform will stifle innovation, says AstraZeneca's Stefan Woxström ... More
EMA CHMP recommends AstraZeneca's Voydeya for PNH treatment Pharmaceutical Technology - 27 Feb 2024 EMA CHMP recommends AstraZeneca's Voydeya for PNH treatment ... More
AstraZeneca's Danicopan Among Four Orphans Up For EU Approval Decision Pink Sheet - 19 Feb 2024 AstraZeneca's Danicopan Among Four Orphans Up For EU Approval Decision ... More
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA The Scientist - 08 Apr 2021 Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA ... More
EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risks FRANCE 24 English - 16 Mar 2021 EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risks ... More
EMA validates Daiichi Sankyo-AstraZeneca's cancer therapy applications Pharmaceutical Business Review - 04 Mar 2024 EMA validates Daiichi Sankyo-AstraZeneca's cancer therapy applications ... More
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small ... Business Wire - 04 Mar 2024 Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small ... ... More
European Medicines Agency: AstraZeneca Vaccine Safe - Benefits Outweigh Risks - Despite Possible Rare Events Health Policy Watch - 18 Mar 2021 European Medicines Agency: AstraZeneca Vaccine Safe - Benefits Outweigh Risks - Despite Possible Rare Events ... More
COVID-19: WHO and European Medicines Agency to meet on AstraZeneca vaccine UN News - 15 Mar 2021 COVID-19: WHO and European Medicines Agency to meet on AstraZeneca vaccine ... More
AstraZeneca's Soliris given EU CHMP recommendation for marketing authorisation - PharmaTimes PharmaTimes - 26 Jun 2023 AstraZeneca's Soliris given EU CHMP recommendation for marketing authorisation - PharmaTimes ... More
EMA has 'not yet reached conclusion' on AstraZeneca Medical Xpress - 06 Apr 2021 EMA has 'not yet reached conclusion' on AstraZeneca ... More
EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot Reuters - 14 Jan 2022 EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot ... More
EMA CHMP issues positive opinion for AstraZeneca's Soliris Pharmaceutical Technology - 27 Jun 2023 EMA CHMP issues positive opinion for AstraZeneca's Soliris ... More
EMA dismisses thyroid cancer link with anti-obesity GLP-1 receptor agonists Pharmaceutical Technology - 30 Oct 2023 EMA dismisses thyroid cancer link with anti-obesity GLP-1 receptor agonists ... More